While Jeff Steven Drobny spends most of his time at his firm Garda Capital Partners in Minneapolis, Minnesota, he also maintains a part-time residence in Scottsdale, Arizona. Jeff Drobny is a dedicated supporter of several charities in Arizona and beyond, including the American Cancer Society.
The American Cancer Society has a strong focus on cancer research, and has helped make almost every research breakthrough since 1946 possible. One area of cancer research that is getting a fair amount of attention these days is immunotherapy and cancer vaccines.
Vaccines work by introducing a innate or weakened virus or bacteria into someone’s body in order to help their immune system identify and fight against the pathogen. Some cancers are actually caused by viruses like human papillomavirus and hepatitis B, so traditional vaccines like these can prevent cancer by preventing those viruses.
Many cancers are not, however, caused by infections. Researchers still don’t know exactly how certain cancers are caused, so it would be impossible to create a preventative vaccine for every form of cancer. Vaccines can also be used treat a cancer that already exists. Cancer cells are mutated versions of healthy cells that already exist in the body, so the immune system can have a harder time identifying and fighting against them. A cancer vaccine can help teach the body what kinds of cells to destroy in order to return the body to a healthy state. Since the immune system has its own memory, the theory is that if the immune system can learn to fight a certain type of cancer, that cancer would be much less likely to recur.